Advancements In Digital Health Applications In Clinical Trials

By Jeremy Wyatt, CEO, ActiGraph

Reflecting on the past year, the digital health industry has made significant strides, especially in digital measures for clinical research. These achievements were made possible by the determination and hard work of our dedicated digital health community, paving the way for a promising future.

In this article, the author recaps several key advancements, including:

• Regulatory Acceptance of Digital Health Technologies (DHTs)
• Precompetitive Collaboration Among Biopharma
• The Rise of Novel Digital Measures
• Continued Focus on Patients and Patient Centricity

While celebrating these accomplishments, ActiGraph's CEO confirms the company's commitment persists in leading innovations in digital health technology for clinical research. "Our team is dedicated to providing cutting-edge solutions that empower researchers, enhance patient experiences, and contribute to improving human health," writes Wyatt. Anticipating a future of collaboration and innovation, ActiGraph aims to collectively shape the landscape of digital health applications in clinical research.